About Us | 合法醫療器材資訊網

PQ Bypass technologies were created by physicians for physicians and their patients suffering from PAD. Our innovations include the TORUS Stent Graft, ... Read More

The intended result is a large lumen, endograft bypass that delivers unobstructed, pulsatile flow from the SFA ostium to the popliteal artery. The PQ Bypass ... Read More

PQ Bypass is a former Company-In-Residence at the renowned Fogarty Institute for Innovation and is operated by recognized leaders in the medical device industry ... Read More

The latest news on PQ Bypass and the DETOUR and TORUS Clinical Trials. Read More

2021年4月14日 — PQ Bypass' proprietary Detour platform for percutaneous femoral-popliteal bypass has been designated by the US Food and Drug Administration ... Read More

PQ Bypass has announced enrolment of the final subject in the company's DETOUR II investigational device exemption (IDE) clinical trial. This milestone occurs ... Read More

2021年4月13日 — PQ Bypass, Inc. is a medical device pioneer bringing new advancements to the treatment of advanced peripheral artery disease (PAD). PQ Bypass ... Read More

2021年4月14日 — Deerfield Management owned Endologix has acquired medical technology company PQ Bypass to bolster vascular reach to treat unmet medical ... Read More

2021年4月14日 — PQ Bypass Inc. is a medical device pioneer bringing new advancements to the treatment of advanced peripheral artery disease. PQ Bypass devices ... Read More

PQ Bypass, Inc. is a Silicon Valley-based medical device company dedicated to transforming the treatment of long-segment peripheral artery disease with ... Read More